PZPío Zelaya-Castro

Pío Zelaya-Castro

*This is an algorithmically generated author record based on publicly available information.

Pío Zelaya-Castro has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neurologic presentation unmasks arrhythmogenic channelopathy: KCNH2 variant Long-QT syndrome managed with subcutaneous implantable cardioverter-defibrillator. A case report

    by Alexis Vallejos-Barrientos, Alessandra Centeno-Araujo, Richard Soto-Becerra, Mario Cabrera-Saldaña, Carolina Guevara-Caicedo, Ana Cecilia Gonzales-Luna, Marisel Payano-Rojas, Ángel Cueva-Parra, Ronal Calle-García, Carlos Ramos-Godoy, et al.

    A previously healthy 10-year-old boy developed febrile seizure-like episodes after an appendectomy, which were diagnosed as epilepsy despite a normal electroencephalogram. He later presented with dyspnea and palpitations and was prescribed propafenone for frequent premature ventricular complexes. The electrocardiogram showed a markedly prolonged QTc interval of 550 ms with a notched T wave in lead V2. Phenytoin and propafenone were discontinued, and propranolol was initiated, but QTc prolongation persisted. The combination of severely prolonged QTc, characteristic T-wave morphology, and absence of structural heart disease redirected the diagnosis toward a repolarization channelopathy; genetic testing confirmed long-QT syndrome type 2 due to a pathogenic KCNH2 c.1814C>T variant. β-blocker therapy was optimized, QT-prolonging triggers were avoided, and a subcutaneous implantable cardioverter-defibrillator was implanted. Cascade genetic screening identified no additional KCNH2 carriers. One variant-negative sister had frequent idiopathic right ventricular outflow tract premature ventricular complexes and was referred for catheter ablation.

  • Open Access

    Un paciente, tres arritmias. Reporte de caso

    by Angel Cueva-Parra, Ana Cecilia Gonzales-Luna, Marisel Payano-Rojas, Mario Cabrera-Saldaña, Richard Soto-Becerra, Carolina Guevara-Caicedo, Pio Zelaya-Castro

    Los pacientes posoperados cardíacos pueden tener más de una arritmia, debido a los cambios anatómicos propios de la cardiopatía congénita, así como a las cicatrices posquirúrgicas. La arritmia más frecuente en este tipo de pacientes es, por lejos, el flutter auricular, siendo la ablación con catéter el tratamiento ideal. Tras la ablación exitosa de la arritmia, es importante realizar maniobras de inducción por la posibilidad de que existan más macroreentradas. Se reporta el caso de una paciente de 55 años, con antecedentes de corrección quirúrgica de comunicación interauricular, que ingresó a un estudio electrofisiológico y ablación de flutter auricular con sistema tridimensional, con cero fluoroscopia y ecocardiograma intracardiaco. Durante el estudio, presentó tres arritmias diferentes (dos flutters y una taquicardia por reentrada del nodo AV), todas ablacionadas con éxito en el mismo procedimiento.

  • Open Access

    Combined leadless pacing and subcutaneous defibrillation strategy in a high-risk patient: first case report from Peru

    by Alexis Vallejos-Barrientos, Diego Davila-Flores, Richard Soto-Becerra, Mario Cabrera-Saldaña, Carolina Guevara-Caicedo, Ana Cecilia Gonzales-Luna, Ángel Cueva-Parra, Marisel Payano-Rojas, Pío Zelaya-Castro

    We present the case of a 51-year-old male with non-ischemic dilated cardiomyopathy and complete atrioventricular block, who was previously implanted with a cardiac resynchronization therapy defibrillator. The patient developed signs of pocket infection with a high risk of extrusion. Partial system extraction was performed, followed by 14 days of intravenous antibiotic therapy. Due to a history of ventricular fibrillation and permanent pacing dependency, and in the absence of viable transvenous access, a sequential implantation strategy was adopted using a leadless pacemaker (Micra AV, Medtronic) and a subcutaneous implantable cardioverter-defibrillator (EMBLEM, Boston Scientific). Both procedures were completed without complications, and the patient showed favorable recovery, with effective pacing, no arrhythmic recurrences, and no signs of infection at the six-month follow-up. This case illustrates the feasibility of a fully leadless approach in high-risk patients with contraindications to conventional transvenous systems.